HomeProductsBuilding BlocksHeterocyclic ScaffoldsTetrazolesPemirolast
Chemical structure of CAS 69372-19-6

Pemirolast

CAS No.69372-19-6
MDL No.N/A
MFC10H8N6O
MW228.21
InChI KeyHIANJWSAHKJQTH-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Pemirolast is a pyridopyrimidine.

CAS No.69372-19-6
Product NamePemirolast

Associated Conditions

Abdominal Aortic Aneurysm·Becker muscular dystrophy·Duchenne muscular dystrophy·asthma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.

Biological & pharmaceutical bulletin • Vol. 28, Issue 3 • 2005
PMID: 15744071DOI: 10.1248/bpb.28.473

Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.

Neuropharmacology • Vol. 46, Issue 6 • 2004
PMID: 15033348DOI: 10.1016/j.neuropharm.2003.11.018

A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics • Vol. 20, Issue 2 • 2004
PMID: 15117570DOI: 10.1089/108076804773710812

Acute asthma attack caused by ophthalmic application of antiallergic agents.

Japanese journal of ophthalmology • Vol. 48, Issue 5 • 2004
PMID: 15486771DOI: 10.1007/s10384-004-0091-x

Documentation